BIRC5 and gastric cancer: This work aims to assess immunoreactivity of p27 and survivin in chronic gastritis, gastric precancerous lesions (H. pylori gastritis and intestinal metaplasia), and intestinal-type gastric cancer, to assess their role as prognostic indicators of progression of precancerous lesions to gastric cancer.